La epilepsia como enfermedad más frecuente en Consulta Externa de Neurología del año 2014 del Hospital León Becerra del cantón Milagro de la provincia del Guayas
No hay miniatura disponible
Archivos
Fecha
2015
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Escuela de Medicina
Resumen
Introducción La epilepsia es un trastorno neurológico muy usual, el cual perjudica alrededor de 50 millones de personas el mundo. Frecuentemente se asocia con complicaciones graves, que implica muerte súbita, lesiones de diversos tipos, y trastornos mentales; además se vincula con problemas sociales, económicos y se la considera un problema de salud pública. Últimamente ha habido preocupación por los costes en su diagnóstico y tratamiento. Objetivo. Calcular los costos del tratamiento en la población de Milagro para el hospital León Pacientes y métodos. Estudio retrospectivo en cuatro grupos de pacientes: diagnóstico reciente (DR), remisión (R), crisis ocasionales (CO), activos sin resistencia a fármacos (ASRF). Se tabularon datos clínicos y económicos por grupo, considerando un año de tratamiento, además se comparó con otros países Resultados. Se analizaron 110 individuos, es decir, el 0.23% del total de pacientes del León Becerra de 52 varones (52%) y 37 de ellos con trabajo estable (16%).Del total de exámenes solicitados, éstos se distribuyeron de la forma siguiente: 100 (35%) niveles de FAE, 80 neuroimágenes: 10 RM cerebral (3.5%) y 70 tomografía axial computarizada (TAC) cerebral (25%); 50 (17%) EEG, 40 (14%) otros exámenes de sangre, líquido cefalorraquídeo (LCR), etc. Los grupos que tienen mayores consultas neurológicas son ASRF. Los grupos que menos fármacos utilizan son DR y R.En el grupo DR (11 pacientes), el coste por paciente y año es de 443 USD.En el grupo R (34 pacientes), el coste por paciente y año es de 316 USD. En el grupo CO (56 pacientes), el coste por paciente y año es de 430 USD.En el grupo ASRF (9 pacientes), el coste por paciente y año es de 711 USD.El grupo DR es el que tiene mayor gasto en estos elementos, especialmente en exámenes El mayor gasto es en medicamentos con un 81,1%, luego con un porcentaje muy inferior exámenes de laboratorios, seguido de las consultas neurológicas (4,3%), exámenes neuroimágenes (2,0%), EEG (1,9%) y finalmente otras consultas (1,4%). El coste directo total por paciente y por año alcanza los 770 USD.
Introduction Epilepsy is a common neurological disorder, which impairs around 50 million people worldwide. It is frequently associated with serious complications involving sudden death, injuries of various kinds, and mental disorders; also it is linked to social, economic problems and is considered a problem of public health. Lately there has been concern about the costs in their diagnosis and treatment. Objective. Calculate the costs of treatment in the town of Leon Becerra de Milagro hospital Patients and methods. Retrospective study in four groups of patients: recent diagnosis (RD), remission (R), occasional crises (CO), no drug resistance (ASRF) assets. Clinical and economic data was tabulated by group, considering a year of treatment, and was compared with other countries Results. 110 individuals were tested, ie 0.23% of patients in the León Becerra of 52 men (52%) and 37 of them with stable (16%) work. Of the total tests ordered, they were distributed as follows 100 (35%) levels of AEDs, 80 neuroimaging: 10 brain MRI (3.5%) and 70 computed tomography (CT) brain (25%); 50 (17%) EEG, 40 (14%) Other blood tests, cerebrospinal fluid (CSF), etc. The groups that are most neurological consultations are ASRF. The groups that use fewer drugs are DR and A. In the DR (11 patients), the cost per patient per year is 443 USD.En the R group (34 patients), the cost per patient per year is 316 USD. In the CO group (56 patients), the cost per patient per year is 430 USD.En the ASRF group (9 patients), the cost per patient per year is 711 USD.El DR group is the one with more spending these items, especially on tests The higher spending on prescription is 81.1%, then with a much lower percentage laboratory tests, followed by neurological consultations (4.3%), neuroimaging examinations (2.0%), EEG (1.9%) and finally other consultations (1.4%). The total direct cost per patient per year reach 770 USD.
Introduction Epilepsy is a common neurological disorder, which impairs around 50 million people worldwide. It is frequently associated with serious complications involving sudden death, injuries of various kinds, and mental disorders; also it is linked to social, economic problems and is considered a problem of public health. Lately there has been concern about the costs in their diagnosis and treatment. Objective. Calculate the costs of treatment in the town of Leon Becerra de Milagro hospital Patients and methods. Retrospective study in four groups of patients: recent diagnosis (RD), remission (R), occasional crises (CO), no drug resistance (ASRF) assets. Clinical and economic data was tabulated by group, considering a year of treatment, and was compared with other countries Results. 110 individuals were tested, ie 0.23% of patients in the León Becerra of 52 men (52%) and 37 of them with stable (16%) work. Of the total tests ordered, they were distributed as follows 100 (35%) levels of AEDs, 80 neuroimaging: 10 brain MRI (3.5%) and 70 computed tomography (CT) brain (25%); 50 (17%) EEG, 40 (14%) Other blood tests, cerebrospinal fluid (CSF), etc. The groups that are most neurological consultations are ASRF. The groups that use fewer drugs are DR and A. In the DR (11 patients), the cost per patient per year is 443 USD.En the R group (34 patients), the cost per patient per year is 316 USD. In the CO group (56 patients), the cost per patient per year is 430 USD.En the ASRF group (9 patients), the cost per patient per year is 711 USD.El DR group is the one with more spending these items, especially on tests The higher spending on prescription is 81.1%, then with a much lower percentage laboratory tests, followed by neurological consultations (4.3%), neuroimaging examinations (2.0%), EEG (1.9%) and finally other consultations (1.4%). The total direct cost per patient per year reach 770 USD.
Descripción
PDF
Palabras clave
Anticonvulsivantes, Epilepsia, Enfermedades del sistema nervioso, Muerte súbita, Trastornos mentales, Estudios retrospectivos, Hospital General Dr. León Becerra Camacho, Cantón Milagro, Ecuador